Psomagen, Inc. (KOSDAQ: A950200)
Health Care · Biotechnology · US
₩2,980.00
-4.33% today · -19.9% 1Y
Psomagen, Inc. (KOSDAQ: A950200) operates in the Biotechnology industry within the Health Care sector. The company is valued at $42.56M.
Over the last twelve months the share price has lost 19.9%, trading between 2.38K and 4.69K.
Tweenvest scores Psomagen, Inc. across four factors: quality 71/100, value 87/100. Its strongest factor is value.
A950200 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.56M
- Revenue (TTM)
- $39.88M
- P/E
- —
- EPS
- -79.24
- Dividend yield
- —
- Beta (5Y)
- -0.20
- 52-week high
- ₩4,690.00
- 52-week low
- ₩2,380.00
- Avg volume (3M)
- —
- Shares outstanding
- 19.24M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| KoBioLabs, IncKOSDAQ: A348150 | $43.11M | ₩2,990.00 | +12.20% |
| ABION Inc.KOSDAQ: A203400 | $43.09M | ₩— | — |
| Holy Stone Healthcare Co., Ltd.TPEX: 4194 | $42.80M | NT$9.34 | +29.18% |
| TegoScience Inc.KOSDAQ: A191420 | $42.57M | ₩7,160.00 | -0.42% |
| Lite Strategy, Inc.NasdaqCM: LITS | $41.96M | $1.22 | -11.59% |
| HLB Panagene Co., Ltd.KOSDAQ: A046210 | $41.58M | ₩1,230.00 | +11.62% |
| Mendus AB (publ)OM: IMMU | $40.97M | Skr5.85 | -5.65% |
| Genomics BioSci & Tech. Co.,Ltd.TWSE: 4195 | $39.93M | NT$15.90 | +10.42% |
Figures last refreshed Oct 4, 2026.